Cargando…
PPAR-δ Agonist With Mesenchymal Stem Cells Induces Type II Collagen-Producing Chondrocytes in Human Arthritic Synovial Fluid
Osteoarthritis (OA) is an inflammatory joint disease characterized by degeneration of articular cartilage within synovial joints. An estimated 27 million Americans suffer from OA, and the population is expected to reach 67 million in the United States by 2030. Thus, it is urgent to find an effective...
Autores principales: | Heck, Bruce E., Park, Joshua J., Makani, Vishruti, Kim, Eun-Cheol, Kim, Dong Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680970/ https://www.ncbi.nlm.nih.gov/pubmed/28901183 http://dx.doi.org/10.1177/0963689717720278 |
Ejemplares similares
-
PPAR-δ agonist affects adipo-chondrogenic differentiation of human mesenchymal stem cells through the expression of PPAR-γ
por: Kim, Dong Hyun, et al.
Publicado: (2020) -
PPARδ Agonist Promotes Type II Cartilage Formation in a Rabbit Osteochondral Defect Model
por: Song, Ju-Yong, et al.
Publicado: (2022) -
Structure-Based Virtual Screening and Discovery of New PPARδ/γ Dual Agonist and PPARδ and γ Agonists
por: Maltarollo, Vinicius G., et al.
Publicado: (2015) -
Effect of Arthritic Synovial Fluids on the Expression of Immunomodulatory Factors by Mesenchymal Stem Cells: An Explorative in vitro Study
por: Leijs, Maarten J. C., et al.
Publicado: (2012) -
NIR-photocatalytic regulation of arthritic synovial microenvironment
por: Zhao, Bin, et al.
Publicado: (2022)